Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-685-9 | CAS number: 124-17-4
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Using 2-(2-butoxyethoxy)ethyl acetate (DEGBEA) , no evidence of mutation was observed in a guideline and GLP (OECD471) bacterial reverse mutation “Ames” study using the Salmonella typhimurium strains TA98, TA100, TA1535, TA1337 and TA1538 with and without metabolic activation. The study was carried out at plate concentrations up to the maximum recommended of 10000ug/plate. There was no evidence for cytotoxicity either at this level. In a separate study, no evidence of mutation was observed in a guideline (OECD472) and GLP bacterial reverse mutation study using E Coli and DEGBEA with and without metabolic activation. The study was carried out at plate concentrations up to the maximum recommended of 10000ug/plate. There was no evidence for cytotoxicity either at this level. Overall, this provides data for all currently required bacterial strains to show that DEGBEA is negative in the bacterial reverse mutation assay(Hoechst, 1988).
There is no further data available on DEGBEA. There is however data on the metabolite of DEGBEA, 2-(2-butoxyethoxy)ethanol (DEGBE). A justification for read across to this substance is included as a separate document within the IUCLID dossier.
The lack of genotoxic potential of DEGBE (and hence DEGBEA) in the bacterial reverse mutation study was confirmed in a recent reverse mutation assay using bacteria strains S. typhimurium strains TA98, TA100, TA1535, TA1537 and E coli WP2uvrA. Tthere was no evidence of mutation with and without metabolic activation up to the maximum dose which did not cause significant cell toxicity (Envigo, 2017).
In an in vitro cytogenicity assay using Chinese Hamster Ovary cells with and without metabolic activation, there was no evidence of cytogenic properties when tested at doses up to those that cause cytotoxicity (Thompson, 1984).
In a GLP and guideline in vitro forward gene mutation assay at the HGPRT locus of CHO cells, DEGBE did not elicit a positive response when tested up to the maximum recommended dose of 5000ul/ml with and without S9 metabolic activation (Lindscombe, 1987).
In a rat hepatocyte unscheduled DNA synthesis assay, DEGBE did not induce any activity when tested at doses up to a level that caused overt cytotoxicity (Thompson, 1984)
Short description of key information:
Reverse mutation in Salmonella bacteria (5 strains), with and
without metabolic activation (Ames): negative
Cytogenicity assay, CHO cells with and without metabolic activation:
negative with surrogate substance.
Gene mutation assay, HGPRT locus of CHO cells with and without metabolic
activation: negative with surrogate substance
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Evidence suggests no significant genotoxic potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
